Europe — EMA

Oprymea (Pramipexole Dihydrochloride Monohydrate)

Pramipexole, the active ingredient in Oprymea, is a dopamine agonist presented as a unknown/unknown for oral use. It treats Parkinson's disease and related motor symptoms in adults.

Pramipexole Dihydrochloride Monohydrate

Request sourcing

Pack/s

What is Pramipexole Dihydrochloride Monohydrate?

Pramipexole, the active ingredient in Oprymea, is a dopamine agonist presented as a unknown/unknown for oral use. It treats Parkinson's disease and related motor symptoms in adults. GNH USA supplies Oprymea as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Pramipexole Dihydrochloride Monohydrate used for?

Pramipexole is a dopamine‑reacting … … … … .... … … … … ... … ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →